AnalystsRoy BuchananRoy Buchanan's Stock Forecasts
AnalystsRoy Buchanan
Sectors:
Analyst Ranking
Bottom 1%
#4563 out of 4595 analysts
Average Return
-19.81%
Win Rate
34%11 out of 32
Risk vs Reward
Poor
Good
Roy Buchanan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pardes Biosciences IncPRDS | +81.51% | $1.19 | $2.16 | 2022-12-13 - 2023-08-30 | Buy |
Pardes Biosciences IncPRDS | +60.00% | $1.35 | $2.16 | 2023-03-15 - 2023-08-30 | Buy |
Arbutus Biopharma CorpABUS | +50.67% | $2.23 | $3.36 | 2023-07-06 - 2024-05-31 | Buy |
Inovio Pharmaceuticals IncINO | +47.45% | $6.87 | $10.13 | 2024-01-04 - 2024-05-31 | Buy |
Dynavax Technologies CorpDVAX | +36.27% | $10.45 | $14.24 | 2022-09-27 - 2023-09-26 | Buy |
Roy Buchanan Analyst Color
Get additional color on Roy Buchanan's coverage of popular stocks
Roy Buchanan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Enanta Pharmaceuticals IncENTA | 7 | Buy | $22.00 | +76.42% | Maintains | a month ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | +19.05% | Reiterates | 2 months ago |
Gritstone Bio IncGRTS | 2 | Buy | $5.00 | +545.99% | Maintains | 2 months ago |
An2 Therapeutics IncANTX | 2 | Buy | $6.00 | +201.51% | Upgrades | 2 months ago |
Inovio Pharmaceuticals IncINO | 1 | Buy | $12.00 | +18.46% | Initiates Coverage On | 5 months ago |
Dynavax Technologies CorpDVAX | 5 | Buy | $27.00 | +125.19% | Maintains | 7 months ago |
Curevac NvCVAC | 4 | Buy | $24.00 | N/A | Maintains | a year ago |
Pardes Biosciences IncPRDS | 2 | Buy | $5.00 | N/A | Maintains | a year ago |
Esperion Therapeutics IncESPR | 1 | Buy | $15.00 | N/A | Reiterates | a year ago |
Argenx SeARGX | 2 | Buy | $448.00 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 1 | Hold | $16.00 | N/A | Maintains | a year ago |
Ibio IncIBIO | 1 | Buy | $750.00 | N/A | Initiates Coverage On | 3 years ago |
Polypid LtdPYPD | 1 | Buy | $420.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.